Compass Pathways stock reversed higher Tuesday on positive test results for its psychedelic drug in treatment-resistant depression.

Compass has already submitted for approval of its psilocybin-based therapy to the FDA following previous Phase III success.

Compass Pathways posted 26-week data from its trial evaluating COMP360, showing rapid and durable benefits, while maintaining ...

Introduction The Jeep Compass Still Trails the Best Compact SUVs Jeep’s small SUV has a peppy engine and an attractive interior, but it can’t overcome numerous flaws Overview.

The footnote should read that we're dealing with a range figure according to the permissive WLTP standard, whereas the EPA would surely reduce that count ...